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Introduction
The term synovial sarcoma refers to morphology that
resembles developing synovium,1 and it is a malignant
mesenchymal neoplasm that mainly occurs in the vicinity
of joint capsules’ bursal and tendon sheaths.2,3 It usually
develops among young adults, and the para-articular
regions are the most diagnosed sites.4,5 According to
previous reports,2,5–7 only 5–10% of synovial sarcomas
are in the head and neck, mediastinum, abdominal wall,
esophagus and retroperitoneum. To date, synovial sar-
comas have also been found to occur in several unusual
locations, including skin, blood vessels, nerves, media-
stinum, pleural cavity, prostate and kidney.8–14 Primary
intra-abdominal synovial sarcoma has been mentioned
as a rare case in several reports.5,15–17 We describe an
unusual case of primary intra-abdominal synovial sar-
coma that was discovered in the omentum, and its
pathologic and clinical features are briefly discussed.
Case Report
A 66-year-old man was admitted to Kaohsiung Military
General Hospital due to intermittent onset of abdom-
inal fullness for 2 months and tenesmus for 2 weeks.
A history of hypertension and alcohol consumption
for more than 30 years was noted. On physical exami-
nation, a palpable mass measuring about 10 × 15 cm
in the left abdomen, with hard constitution and defi-
nite margin, was detected. The pulse rate and blood
pressure were 82/min and 140/82 mmHg, respec-
tively. Complete blood cell count showed: hemoglo-
bin, 9.7 g/dL; mean corpuscular volume, 89.2 fL;
white blood cell count, 15.3 × 103 cells/μL; polymor-
phonuclear leukocytes, 69.4%; lactate dehydrogenase,
356 U/L.
Computed tomography (CT) showed a huge het-
erogeneous lower attenuation mass with an amorphous
solid component and a thin capsule; it was situated
between the stomach and colon. In addition, the lesion
was over the middle abdomen, extending from S2 and
S3 of the liver to the transverse colon (Figure 1A).
Body fluid near the mass and in the intraperitoneal
cavity was presumably hemoperitoneum due to tumor
bleeding (Figure 1B). The associated symptoms in this
patient were body weight loss (5 kg within 2 months),
lack of appetite, reduced stool passage and increased
urination frequency.
A huge fragile mass (20 × 20 × 10 cm) with rupture
of the capsule occupying the upper abdomen with
compression of the stomach was found intraoperatively.
The tumor mass was bulging out from the anterior wall
and body of the stomach: the lesser curvature part
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directly invaded into the lateral segment of the liver
and downward to extend below the umbilicus with-
out invasion of the colon and mesocolon. A nodular
lesion about 1 cm in diameter seeding over the sur-
face on the left lateral segment of the liver and multi-
ple nodular lesions seeding over the surface of the left
diaphragm were cleared. Moreover, liver cirrhosis was
also diagnosed. Left lateral segmentectomy of the liver,
subtotal gastrectomy with Billroth’s II anastomosis
and extensive resection of the left diaphragm tumor
were performed.
The gross specimen comprised resected stomach,
omentum and liver. Histologic examination demon-
strated a biphasic pattern with proliferative sarcomatous
cells arranged in abortive glands or rounded nests
among fascicular growth of spindle cells featuring a
herring-bone pattern (Figure 2). Immunohistochemical
staining showed that the major cell types were spindle
and epithelial cells; furthermore, the tumor cells also
possessed histologic similarity of epithelial membrane
antigen (EMA) and cytokeratin. The spindle cells were
positive for bcl-2, negative for smooth muscle actin
(SMA), S-100, CD117, hepatocyte antigen and cal-
retinin. These findings helped us to exclude leiomyo-
sarcoma, malignant peripheral nerve sheath tumor
(MPNST, malignant schwannoma), gastrointestinal
stromal tumor (GIST), hepatic cellular carcinoma and
mesothelioma. The diagnosis of synovial sarcoma was
confirmed and documented.
After operation, the patient was hospitalized for
10 days and then discharged. However, 2 months later,
he was readmitted to our emergency room due to con-
sciousness disturbance and severe abdominal distension
and pain. Abdominal CT found recurrence of multiple
nodular lesions over the peritoneal area, perirectal area,
left lateral region of the urinary bladder and mesen-
teric area. In addition, multiple lymphadenopathies
over the right external iliac lymph chain and massive
ascites were found. The patient died 10 days later due
to poor and worsening condition.
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Figure 1. Synovial sarcoma: (A) noncontrast computed tomography (CT) shows a huge, low attenuation mass in the omentum (arrows);
(B) postcontrast CT shows an enhanced, heterogeneous lesion involving the inferior liver and anterior stomach (arrows).
BA
Figure 2. Histology shows that the tumor has a biphasic pattern. The sarcomatous component demonstrates fascicular growth of spin-
dle cells featuring a herring-bone pattern (black arrows). The epithelial component is in rounds nests of epithelial cells with ovoid nuclei
and abundant cytoplasm (arrowheads). (A) 40×; (B) 100×.
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Discussion
Intra-abdominal synovial sarcoma is rarely found.
Immunohistochemistry is useful for diagnosing and
distinguishing synovial sarcoma from other malignan-
cies. Most synovial sarcomas are focally positive for
cytokeratin and EMA. It has recently been suggested
that EMA, cytokeratin AE1/AE3, and E-cadherin, 
in combination with CD34 negativity, are the most
useful and sensitive protein biomarkers for diagnosing
monophasic fibrous pattern, and also good for diag-
nosing the scantily differentiated synovial sarcoma.18
In addition, bcl-2 and vimentin were reported as
being diffusely expressed in spindle cells of synovial
sarcoma. In our case, immunostaining was positive
for EMA, cytokeratin AE1/AE3, bcl-2 and vimentin,
negative for S-100 protein, and there was a lack of
ultrastructural features of Schwann’s cells, which led
us to exclude MPNST. The negative results for SMA,
CD117, hepatocyte and calretinin led us to exclude
leiomyosarcoma, GIST, hepatic cell carcinoma and
mesothelioma. This case was compatible with bipha-
sic synovial sarcoma according to light-field micro-
scopic and immunohistochemical findings.
To the best of our knowledge, this is the first
reported case of synovial sarcoma in the omentum.
Synovial sarcomas are aggressive tumors. Up to 50% of
synovial sarcomas recur locally within 2 years. Metastases
occur mainly to the lungs, and less commonly to the
lymph nodes and bones. According to previous
reports,19,20 all patients with primary retroperitoneal
synovial sarcoma died (at intervals of 7–24 months)
with local recurrence or extension, but none metasta-
sized outside the abdomen. It has been shown that
the translocation t(X;18)(p11.2;q11.2) is a characteris-
tic chromosome aberration in more than 90% of syn-
ovial sarcoma.21 Monophasic tumors have either SSX1
(about 60%) or SSX2 in their rearrangement, but the
majority of biphasic tumors (defined as having distinct
gland formation with lumna) have the SSX1 rearrange-
ment.22 In this patient, the formalin-fixed paraffin-
embedded tissue was submitted for molecular analysis
using reverse transcription–polymerase chain reaction
to determine the specific genetic aberration of this syn-
ovial sarcoma. Unfortunately, the molecular evidence
was not confirmed due to RNA decay during the
experimental procedures.
Carcinogenesis seems to be a multistage process,
wherein the primary causal event of synovial sarcoma
is presumably the chromosomal translocation. The
monophasic and undifferentiated synovial sarcoma
might be difficult to distinguish from other tumors, such
as fibrosarcomas, malignant schwannomas, malignant
fibrous histiocytomas and, in rare instances, carcino-
mas such as adenocarcinomas.23 In this case, local
recurrence in the retroperitoneal region and bladder
with massive ascites developed 2 months after complete
resection of the primary tumor. Descending aggression
was noted and supposed to be the main reason causing
death in this patient. In conclusion, synovial sarcoma
is a high-grademalignancy with highly metastatic poten-
tial; correct and early diagnosis of synovial sarcoma may
impact treatment.
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